Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2

Histochemistry and Cell Biology

Volumn 138, Issue 4, 2012, Pages 699-707

  Giagnacovo, M ^a   Malatesta, M ^b   Cardani, R ^c,d   Meola, G ^c   Pellicciari, C ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d CMN   (Italy)

Author keywords

Cell cycle; Fibroblasts; Fluorescence microscopy; Immunocytochemistry; Myotonic dystrophy; Nuclear foci; Skeletal muscle fibers

Indexed keywords

MUSCLE PROTEIN; MUSCLEBLIND LIKE 1 PROTEIN; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL NUCLEUS; CELL TYPE; CHROMOSOME; CYTOPLASM; DYNAMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INTERPHASE; MALE; MITOSIS; MORPHOMETRICS; MUSCLE BIOPSY; MYOTONIC DYSTROPHY; NUCLEAR FOCUS; PRIORITY JOURNAL; RNA PROCESSING; SKIN FIBROBLAST; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SIZE; CELLS, CULTURED; FIBROBLASTS; HUMANS; INTERPHASE; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MUSCLE, SKELETAL; MYOTONIC DISORDERS; NUCLEAR PROTEINS; RIBONUCLEOPROTEINS;

EID: 84867336680     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-012-0984-6     Document Type: Article

References (48)

1. Andrade LE, Tan EM, Chan EK (1993) Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation. Proc Natl Acad Sci USA 90:1947-1951
2. Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, Thornton CA, Moxley RT, Harper PS, Rogers MT, Jurkat-Rott K, Lehmann-Horn F, Wieser T, Gamez J, Navarro C, Bottani A, Kohler A, Shriver MD, Sallinen R, Wessman M, Zhang S, Wright FA, Krahe R (2003) Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Gen 73:835-848
3. Biggiogera M, Pellicciari C (2000) Heterogeneous ectopic RNPderived structures (HERDS) are markers of transcriptional arrest. FASEB J 14:828-834
4. Biggiogera M, Bottone MG, Scovassi AI, Soldani C, Vecchio L, Pellicciari C (2004) Rearrangement of nuclear ribonucleoprotein (RNP)-containing structures during apoptosis and transcriptional arrest. Biol Cell 96:603-615
5. Biggiogera M, Cisterna B, Bottone MG, Soldani C, Pellicciari C (2007) Nuclear RNP and nucleolar-Associated proteins during apoptosis: a politically correct form of segregation? Dynamic Cell Biol 1:65-71
6. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 30 end of a transcript encoding a protein kinase family member. Cell 69:385-387
7. Cardani R, Mancinelli E, Sansone V, Rotondo G, Meola G (2004) Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem 48:437-442
8. Cardani R, Mancinelli E, Rotondo G, Sansone V, Meola G (2006) Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Eur J Histochem 50:177-182
9. Cardani R, Mancinelli E, Giagnacovo M, Sansone V, Meola G (2009) Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies. Eur J Histochem 53:107-112
10. Chen YC, Kappel C, Beaudouin J, Eils R, Spector DL (2008) Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis. Mol Biol Cell 19:3147-3162
11. Day JW, Roelofs R, Leroy B, Pech I, Benzow K, Ranum LP (1999) Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromuscul Disord 9:19-27
12. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LP (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60:657-664
13. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira Smith O, Peacocke M, Campisi J (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363-9367
14. Dundr M (2011) Seed and grow: a two-step model for nuclear body biogenesis. J Cell Biol 193:605-606
15. Fakan S (2004) The functional architecture of the nucleus as analysed by ultrastructural cytochemistry. Histochem Cell Biol 122:83-93
16. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, Brook JD (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11:805-814
17. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256-1258
18. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621
19. Holt I, Jacquemin V, Fardaei M, Sewry CA, Butler-Browne GS, Furling D, Brook JD, Morris GE (2009) Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle. Am J Pathol 174:216-227
20. Jones K, Jin B, Iakova P, Huichalaf C, Sarkar P, Schneider-Gold C, Schoser B, Meola G, Shyu AB, Timchenko N, Timchenko L (2011) RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2. Am J Pathol. doi: 10.1016/j.ajpath.2011. 07.013 (in press)
21. Ladd AN, Charlet N, Cooper TA (2001) The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol 21:1285-1296
22. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864-867
23. Llorian M, Smith CW (2011) Decoding muscle alternative splicing. Curr Opin Genet Dev 21:380-387
24. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barceló J, O'Hoy K, Leblond S, Earle-MacDonald J, de Jong PJ, Wieringa B, Korneluk RG (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 30 untranslated region of the gene. Science 255:1253-1255
25. Malatesta M, Zancanaro C, Martin TE, Chan EKL, Amalric F, Lührmann R, Vogel P, Fakan S (1994) Cytochemical and immunocytochemical characterization of nuclear bodies during hibernation. Eur J Cell Biol 65:82-93
26. Malatesta M, Cardinali A, Battistelli S, Zancanaro C, Martin TE, Fakan S, Gazzanelli G (1999) Nuclear bodies are usual constituents in tissues of hibernating dormice. Anat Rec 254:389-395
27. Malatesta M, Giagnacovo M, Cardani R, Meola G, Pellicciari C (2011) RNA processing is altered in skeletal muscle nuclei of patients affected by myotonic dystrophy. Histochem Cell Biol 135:419-425
28. Mankodi A, Teng-Umnuay P, Krym M, Henderson D, Swanson M, Thornton CA (2003) Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol 54:760-768
29. Mehta IS, Figgitt M, Clements CS, Kill IR, Bridger JM (2007) Alterations to nuclear architecture and genome behavior in senescent cells. Ann NY Acad Sci 1100:250-263
30. Meola G, Moxley RT 3rd (2004) Myotonic dystrophy type 2 and related myotonic disorders. J Neurol 251:1173-1182
31. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 19:4439-4448
32. Moxley RT, Meola G (2008) The myotonic dystrophies. Chapter 47. In: Rosenberg RN, Di Mauro S, Paulson HL, Ptacek L, Nestler EJ (eds) The molecular and genetic basis of neurologic and psychiatric disease, 4th edn. Lippincot Williams, Philadelphia
33. Mulders SAM, van den Broek WJAA, Wheeler TM, Croes HJE, van Kuik-Romeijn P, de Kimpe SJ, Furling D, Platenburg GJ, Gourdon G, Thornton CA, Wieringa B, Wansink DG (2009) Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc Natl Acad Sci USA 106:13915-13920
34. Perdoni F, Malatesta M, Cardani R, Giagnacovo M, Mancinelli E, Meola G, Pellicciari C (2009) RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study. Eur J Histochem 53:151-158
35. Querido E, Gallardo F, Beaudoin M, Ménard C, Chartrand P (2011) Stochastic and reversible aggregation of mRNA with expanded CUG-Triplet repeats. J Cell Sci 124:1703-1714
36. Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW (1998) Genetic mapping of a second myotonic dystrophy locus. Nat Genet 19:196-198
37. Rubin H (1997) Cell aging in vivo and in vitro. Mech Ageing Dev 98:1-35
38. Savkur RS, Philips AV, Cooper TA (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29:40-47
39. Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LP, Day JW (2004) Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 74:1309-1313
40. Schoser B, Timchenko L (2010) Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. Curr Genomics 11:77-90
41. Sikora E, Arendt T, Bennett M, Narita M (2011) Impact of cellular senescence signature on ageing research. Ageing Res Rev 10:146-152
42. Smolinski DJ, Wrobel B, Noble A, Zienkiewicz A, Gorska-Brylass A (2011) Periodic expression of Sm proteins parallels formation of nuclear Cajal bodies and cytoplasmic snRNP-rich bodies. Histochem Cell Biol 136:527-541
43. Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, Peltonen L, Krahe R, Udd B (2011) Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Gen 19:776-782
44. Udd B, Meola G, Krahe R, Wansink DG, Bassez G, Kress W, Schoser B, Moxley R (2011) Myotonic dystrophy type 2 (DM2) and related disorders. Neuromusc Disord 21:443-450
45. Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, Mancinelli E, Rouche A, Hogrel JY, Laforêt P, Maisonobe T, Pellissier JF, Krahe R, Eymard B, Udd B (2003) Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 60:1854-1857
46. Wang G-S, Kearney DL, De Biasi M, Taffet G, Cooper TA (2007) Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest 117:2802-2811
47. Warf MB, Nakamori M, Matthys CM, Thornton CA, Berglund JA (2009) Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc Natl Acad Sci USA 106:18551-18556
48. White AE, Leslie ME, Calvi BR, Marzluff WF, Duronio RJ (2007) Developmental and cell cycle regulation of the drosophila histone locus body. Mol Biol Cell 18:2491-2502